UVA researchers have published a new study that could revitalize once-promising treatments that help fight solid cancer tumors, the university announced on Monday. The research successfully laid out why the immunotherapy treatments targeting ovarian, colon and triple-negative breast cancer, succeeded in lab tests but failed in human trials.